Biologics Global Market Report 2024

Description

Biologics are medications derived from organic materials and are utilized to treat a diverse range of illnesses, particularly immune-related conditions such as Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. One intriguing aspect is that biologics are sourced from various natural materials, including carbohydrates, proteins, nucleic acids, or complex mixtures of these substances.

The primary types of biologics include monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are engineered in laboratories to target specific infections. These biologics can be administered through various routes, including oral, parenteral, and others, and are distributed through channels such as hospital pharmacies, retail pharmacies/drug stores, and others.

The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biologics market size has grown strongly in recent years. It will grow from $416.65 billion in 2023 to $454.4 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth observed during the historic period can be attributed to several factors, including an aging population, government initiatives, the ability to command high prices, and an increased need for immunology.

The biologics market size is expected to see rapid growth in the next few years. It will grow to $666.31 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The forecasted growth is driven by increased funding, technological advancements, improved healthcare access, robust research and development activities for oral biologics, a preference for pills over injections, and a growing pipeline of biologics. Key trends include leveraging revised regulations for enhanced biologics development, a shift towards capitalizing on the demand for these drugs, increased investment in innovative biologics R&D, and research focused on biologics for treating complex diseases.

The increasing demand for personalized medicine is indeed a key driver behind the growth of the biologics market. Personalized medicine, also known as precision medicine, tailors medical treatment and healthcare to individual patient characteristics. This approach allows for the customization of biologic treatments based on a patient's specific genetic and clinical profile, marking a transformative shift in the healthcare industry. As evidenced by the Personalized Medicine Coalition's report, a substantial portion, approximately 35%, of new drug approvals in 2021 were personalized medicines, showcasing the rising significance of this sector within the broader pharmaceutical landscape. Consequently, this surge in demand for personalized medicine is expected to drive the growth of the biologics market.

Technology stands out as a continued driving force behind market expansion in this period. Physiology simulation modeling, in particular, is poised for significant development and is anticipated to contribute to market growth. Advances in this field promise greater efficiencies, and companies within the biologics market are likely to benefit from such advancements. Notable instances include the adoption of Amazon's Elastic Compute Cloud (EC2) platform by pharmaceutical giants such as Eli Lilly and Pfizer. These companies utilize this technology for conducting simulation models in early drug discovery, significantly reducing the time required for simulations. For instance, tasks that traditionally took weeks can now be completed within hours. Initiatives such as Lilly's Open Innovation Drug Discovery program further underscore efforts to enhance biologics research and development. These technological advancements are expected to streamline processes, lower costs, and accelerate the development phase of biologics, enabling companies to introduce their products to market more swiftly.

The focus of major companies in the biologics industry on developing innovative products, such as oncology biosimilars, reflects their strategic initiatives to strengthen market positions and gain competitive advantages. Oncology biosimilars, specifically designed to treat cancer, are akin to existing biologic drugs and offer highly similar alternatives in terms of efficacy and safety. An example of this pursuit is seen in the collaboration between Biocon Biologics Limited and Viatris Inc., which led to the launch of Abevmy in Canada in May 2022. Abevmy is an oncology biosimilar utilized for cancer treatment, exhibiting similarity to an already authorized biological medicine.

The revisions made by the US Food and Drug Administration (FDA) in its regulations concerning biologics signify a shift toward eliminating outdated requirements. The alterations allow drug manufacturers to adopt new manufacturing technologies and testing capabilities. Specifically, the FDA has amended regulations to enable the sourcing of standard preparations, critical in ensuring the safety, purity, and potency of biologics, from sources beyond the FDA's Center for Biologics Evaluation and Research (CBER). Additionally, the FDA has removed the minimal potency limits rule (Section 610.21 of FDA code) pertaining to certain antibodies and antigens. Furthermore, updates in regulations (Section 610.53 of FDA code) concerning storage periods and conditions for biologics have been introduced. These regulatory amendments aim to enhance flexibility and promote the adoption of contemporary scientific technologies in the manufacturing processes of licensed biological products, fostering innovation and progress in the biologics industry.

Major companies operating in the biologics market report are Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Wockhardt, Zydus Cadilla, Asahi Glass Co. Ltd., China Biologic Products Holdings Inc., China Regenerative Medicine International, ABLbio, Adimmune, Henlius, Innovent Biologics, Bio-Thera, Hisun Pharma, 3SBio, Beijing ShuangLu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Biocon, Dr.Reddy's, Mylan, Kyowa Hakko Kirin, Takeda, Mitsubishi Tanabe, AGC Biologics, Tonghua Dongbao Pharmaceutical Co., China Regenerative Medicine International, Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Biogen Inc., Novartis, Apotex, Gilead Sciences, Bayer, Abbott Laboratories

North America was the largest region in the biologics market in 2023. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The biologics market consists of sales of tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
2) By Drug Classification: Branded Drugs; Generic Drugs
3) By Route Of Administration: Oral; Other Route Of Administration
4) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines
Companies Mentioned: Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r14355

1. Executive Summary

2. Biologics Market Characteristics

3. Biologics Product/Service Analysis -Product/Service Examples

3.1. Biologics Supply Chain Analysis
- 3.1.1. Biologics Resources
- 3.1.2. Biologics Manufacturers
- 3.1.3. Biologics Distributors and Retailers
- 3.1.4. Biologics End Users
3.2. Biologics Customer Information

4. Biologics Market Trends And Strategies

5. Biologics Market - Macro Economic Scenario

5.1. Impact Of High Inflation On The Market
5.2. Ukraine-Russia War Impact On The Market
5.3. COVID-19 Impact On The Market

6. Global Biologics Market Size and Growth

6.1. Global Biologics Market Drivers and Restraints
- 6.1.1. Drivers Of The Market
- 6.1.2. Restraints Of The Market
6.2. Global Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
6.3. Global Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

7. Biologics Market Segmentation

7.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Monoclonal Antibodies (MAbS)
Therapeutic Proteins
Vaccines
7.2. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Branded Drugs
Generic Drugs
7.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Route Of Administration
7.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription-Based Drugs
Over-The-Counter Drugs
7.5. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Other Distribution Channels

8. Biologics Market Regional And Country Analysis

8.1. Global Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.2. Global Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. Asia-Pacific Biologics Market

9.1. Asia-Pacific Biologics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
9.2. Asia-Pacific Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9.3. Asia-Pacific Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9.4. Asia-Pacific Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10. China Biologics Market

10.1. China Biologics Market Overview
10.2. China Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10.3. China Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10.4. China Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

11. India Biologics Market

11.1. India Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. India Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. India Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Japan Biologics Market

12.1. Japan Biologics Market Overview
12.2. Japan Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Japan Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.4. Japan Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Australia Biologics Market

13.1. Australia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Australia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Australia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. Indonesia Biologics Market

14.1. Indonesia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. Indonesia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. Indonesia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. South Korea Biologics Market

15.1. South Korea Biologics Market Overview
15.2. South Korea Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. South Korea Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. South Korea Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. Bangladesh Biologics Market

16.1. Bangladesh, Biologics Historic Market, 2018 - 2023, $ Billion
16.2. Bangladesh, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

17. Thailand Biologics Market

17.1. Thailand, Biologics Historic Market, 2018 - 2023, $ Billion
17.2. Thailand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

18. Vietnam Biologics Market

18.1. Vietnam, Biologics Historic Market, 2018 - 2023, $ Billion
18.2. Vietnam, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

19. Malaysia Biologics Market

19.1. Malaysia, Biologics Historic Market, 2018 - 2023, $ Billion
19.2. Malaysia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

20. Singapore Biologics Market

20.1. Singapore, Biologics Historic Market, 2018 - 2023, $ Billion
20.2. Singapore, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

21. Philippines Biologics Market

21.1. Philippines, Biologics Historic Market, 2018 - 2023, $ Billion
21.2. Philippines, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

22. Hong kong Biologics Market

22.1. Hong Kong, Biologics Historic Market, 2018 - 2023, $ Billion
22.2. Hong Kong, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

23. New Zealand Biologics Market

23.1. New Zealand, Biologics Historic Market, 2018 - 2023, $ Billion
23.2. New Zealand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

24. Western Europe Biologics Market

24.1. Western Europe Biologics Market Overview
24.2. Western Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. Western Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. Western Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. UK Biologics Market

25.1. UK Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.2. UK Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. UK Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. Germany Biologics Market

26.1. Germany Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.2. Germany Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. Germany Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. France Biologics Market

27.1. France Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. France Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. France Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Italy Biologics Market

28.1. Italy Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.2. Italy Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Italy Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Spain Biologics Market

29.1. Spain Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.2. Spain Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Spain Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Austria Biologics Market

30.1. Austria, Biologics Historic Market, 2018 - 2023, $ Billion
30.2. Austria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

31. Belgium Biologics Market

31.1. Belgium, Biologics Historic Market, 2018 - 2023, $ Billion
31.2. Belgium, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

32. Denmark Biologics Market

32.1. Denmark, Biologics Historic Market, 2018 - 2023, $ Billion
32.2. Denmark, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

33. Finland Biologics Market

33.1. Finland, Biologics Historic Market, 2018 - 2023, $ Billion
33.2. Finland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

34. Ireland Biologics Market

34.1. Ireland, Biologics Historic Market, 2018 - 2023, $ Billion
34.2. Ireland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

35. Netherlands Biologics Market

35.1. Netherlands, Biologics Historic Market, 2018 - 2023, $ Billion
35.2. Netherlands, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

36. Norway Biologics Market

36.1. Norway, Biologics Historic Market, 2018 - 2023, $ Billion
36.2. Norway, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

37. Portugal Biologics Market

37.1. Portugal, Biologics Historic Market, 2018 - 2023, $ Billion
37.2. Portugal, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

38. Sweden Biologics Market

38.1. Sweden, Biologics Historic Market, 2018 - 2023, $ Billion
38.2. Sweden, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

39. Switzerland Biologics Market

39.1. Switzerland, Biologics Historic Market, 2018 - 2023, $ Billion
39.2. Switzerland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

40. Eastern Europe Biologics Market

40.1. Eastern Europe Biologics Market Overview
40.2. Eastern Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
40.3. Eastern Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
40.4. Eastern Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

41. Russia Biologics Market

41.1. Russia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
41.2. Russia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
41.3. Russia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

42. Czech Republic Biologics Market

42.1. Czech Republic, Biologics Historic Market, 2018 - 2023, $ Billion
42.2. Czech Republic, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

43. Poland Biologics Market

43.1. Poland, Biologics Historic Market, 2018 - 2023, $ Billion
43.2. Poland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

44. Romania Biologics Market

44.1. Romania, Biologics Historic Market, 2018 - 2023, $ Billion
44.2. Romania, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

45. Ukraine Biologics Market

45.1. Ukraine, Biologics Historic Market, 2018 - 2023, $ Billion
45.2. Ukraine, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

46. North America Biologics Market

46.1. North America Biologics Market Overview
46.2. North America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
46.3. North America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
46.4. North America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

47. USA Biologics Market

47.1. USA Biologics Market Overview
47.2. USA Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
47.3. USA Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
47.4. USA Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

48. Canada Biologics Market

48.1. Canada Biologics Market Overview
48.2. Canada Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
48.3. Canada Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
48.4. Canada Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

49. Mexico Biologics Market

49.1. Mexico, Biologics Historic Market, 2018 - 2023, $ Billion
49.2. Mexico, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

50. South America Biologics Market

50.1. South America Biologics Market Overview
50.2. South America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
50.3. South America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
50.4. South America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

51. Brazil Biologics Market

51.1. Brazil Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
51.2. Brazil Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
51.3. Brazil Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

52. Chile Biologics Market

52.1. Chile, Biologics Historic Market, 2018 - 2023, $ Billion
52.2. Chile, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

53. Argentina Biologics Market

53.1. Argentina, Biologics Historic Market, 2018 - 2023, $ Billion
53.2. Argentina, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

54. Colombia Biologics Market

54.1. Colombia, Biologics Historic Market, 2018 - 2023, $ Billion
54.2. Colombia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

55. Peru Biologics Market

55.1. Peru, Biologics Historic Market, 2018 - 2023, $ Billion
55.2. Peru, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

56. Middle East Biologics Market

56.1. Middle East Biologics Market Overview
56.2. Middle East Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
56.3. Middle East Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
56.4. Middle East Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

57. Saudi Arabia Biologics Market

57.1. Saudi Arabia, Biologics Historic Market, 2018 - 2023, $ Billion
57.2. Saudi Arabia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

58. Israel Biologics Market

58.1. Israel, Biologics Historic Market, 2018 - 2023, $ Billion
58.2. Israel, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

59. Iran Biologics Market

59.1. Iran, Biologics Historic Market, 2018 - 2023, $ Billion
59.2. Iran, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

60. Turkey Biologics Market

60.1. Turkey, Biologics Historic Market, 2018 - 2023, $ Billion
60.2. Turkey, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

61. United Arab Emirates Biologics Market

61.1. United Arab Emirates, Biologics Historic Market, 2018 - 2023, $ Billion
61.2. United Arab Emirates, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

62. Africa Biologics Market

62.1. Africa Biologics Market Overview
62.2. Africa Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
62.3. Africa Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
62.4. Africa Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

63. Egypt Biologics Market

63.1. Egypt, Biologics Historic Market, 2018 - 2023, $ Billion
63.2. Egypt, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

64. Nigeria Biologics Market

64.1. Nigeria, Biologics Historic Market, 2018 - 2023, $ Billion
64.2. Nigeria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

65. South Africa Biologics Market

65.1. South Africa, Biologics Historic Market, 2018 - 2023, $ Billion
65.2. South Africa, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

66. Biologics Market Competitive Landscape And Company Profiles

66.1. Biologics Market Competitive Landscape
66.2. Biologics Market Company Profiles
- 66.2.1. Merck & Co., Inc.
  - 66.2.1.1. Overview
  - 66.2.1.2. Products and Services
  - 66.2.1.3. Strategy
  - 66.2.1.4. Financial Performance
- 66.2.2. AbbVie Inc.
  - 66.2.2.1. Overview
  - 66.2.2.2. Products and Services
  - 66.2.2.3. Strategy
  - 66.2.2.4. Financial Performance
- 66.2.3. F. Hoffmann-La Roche AG
  - 66.2.3.1. Overview
  - 66.2.3.2. Products and Services
  - 66.2.3.3. Strategy
  - 66.2.3.4. Financial Performance
- 66.2.4. Johnson & Johnson
  - 66.2.4.1. Overview
  - 66.2.4.2. Products and Services
  - 66.2.4.3. Strategy
  - 66.2.4.4. Financial Performance
- 66.2.5. Pfizer Inc.
  - 66.2.5.1. Overview
  - 66.2.5.2. Products and Services
  - 66.2.5.3. Strategy
  - 66.2.5.4. Financial Performance

67. Biologics Market Other Major And Innovative Companies

67.1. Bristol Myers Squibb Company
67.2. Sanofi S.A.
67.3. GlaxoSmithKline Plc.
67.4. Eli Lilly and Company
67.5. Amgen Inc.
67.6. Wockhardt
67.7. Zydus Cadilla
67.8. Asahi Glass Co. Ltd.
67.9. China Biologic Products Holdings Inc.
67.10. China Regenerative Medicine International
67.11. ABLbio
67.12. Adimmune
67.13. Henlius
67.14. Innovent Biologics
67.15. Bio-Thera

68. Global Biologics Market Competitive Benchmarking

69. Global Biologics Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Biologics Market

71. Biologics Market Future Outlook and Potential Analysis

71.1 Biologics Market In 2028 - Countries Offering Most New Opportunities
71.2 Biologics Market In 2028 - Segments Offering Most New Opportunities
71.3 Biologics Market In 2028 - Growth Strategies
- 71.3.1 Market Trend Based Strategies
- 71.3.2 Competitor Strategies

72. Appendix

72.1. Abbreviations
72.2. Currencies
72.3. Historic And Forecast Inflation Rates
72.4. Research Inquiries
72.5. The Business Research Company
72.6. Copyright And Disclaimer